Jonathan Quinonez, DO
Neuromusculoskeletal Medicine & OMM · Riverview, FLNPI 1679013437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 24.5% of the total. Reporting peaked in 2022 at $703 and has fallen 86.6% since, to $94 in 2025.
Across 28 payments — averaging $50.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$350
- Relievant Medsystems, Inc.$312
- SPR Therapeutics, Inc$197
- Amgen$149
- AstraZeneca$140
- Indivior Inc.$89
- plus $190 from 8 others
What the payments were for
- Food & beverage$1,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $350 |
| Relievant Medsystems, Inc. | 2 | $312 |
| SPR Therapeutics, Inc | 2 | $197 |
| Amgen(2 entities) | 2 | $149 |
| AstraZeneca | 2 | $140 |
| Indivior Inc. | 3 | $89 |
| Braeburn Inc. | 2 | $59 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Almatica Pharma LLC | 1 | $20 |
| IBSA Pharma Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$918
- BOTOX$230
- UPLIZNA$130
- ULTOMIRIS$120
- SPRINT PNS System$116
How this compares
$1,426 in reported general payments places this provider in the 80th percentile of 41 neuromusculoskeletal medicine & omm providers in Florida.
See all neuromusculoskeletal medicine & omm providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuromusculoskeletal medicine & omm in Riverview
- Patricio EspinosaBoca Raton$245K
- Hassan BitarBrandon$12K
- Mohamad SalehTemple Terrace$11K
- Issachar DevineLake Mary$6K
- Ramon Lugo-SanchezMiramar$6K
- Chitto SarkarPort St Lucie$2K
- Glenn ChapmanBoynton Beach$2K
- Jesse KemmerlinSouth Miami$2K
- Joel SteinFort Lauderdale$1K
- Xiawei ZhongOrlando$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.